Skip to main content
. 2023 Nov 16;38(1):19–32. doi: 10.1177/02698811231200019

Table 1.

Most applied instruments for assessment of the acute psychedelic experience in clinical research on psychedelics from January 1st, 1990 to May 22nd, 2023.

Instrument N = 93 (1990–2023) % of sample (1990–2023) N = 58 (2016–2023) % of sample (2016–2023)
5D-ASC 54 58.1 40 68.9
VAS/Likert 27 29.0 20 34.4
HRS 23 24.7 9 15.5
MEQ30 15 16.1 15 25.9
SOCQ/MEQ43 14 15.0 9 15.5
ARCI 11 11.8 4 6.9
APZ 10 10.7 2 3.4
EDI 7 7.5 7 12.1
M-scale 6 6.4 3 5.2
CEQ 5 5.4 5 8.6
CADSS 2 2.1 2 3.4
DEQ 2 2.1 2 3.4
NDE 1 1.1 1 1.7
EBI 1 1.1 1 1.7
PSI 1 1.1 1 1.7
PIQ 1 1.1 1 1.7
PIS 1 1.1 1 1.7

Overview of the entire sample and the 8 most recent years from 2016 to 2023.

APZ/OAV: Abnormer Psychischer Zustand; ARCI: Addiction Research Center Inventory; CADSS: Clinician-Administered Dissociative States Scale; CEQ: Challenging Experiences Questionnaire; DEQ: Drug Effects Questionnaire; EBI: Emotional Breakthrough Inventory; EDI: Ego Dissolution Inventory; HRS: Hallucinogen Rating Scale; MEQ30: Mystical Experience Questionnaire 30 items; M-scale: Hood Mysticism Scale; NDE: Near-Death Experience Questionnaire; PIS: Psychological Insight Scale; PIQ: Psychological Insight Questionnaire; PSI: Psychotomimetic States Inventory; SOCQ: States of Consciousness Questionnaire; VAS: Visual analog scales developed for the studies; 5D-ASC: Five-Dimension Altered States of Conscious Questionnaire.